Back

Plasma proteomics identify fibroblast growth factor 5 as a biomarker for genetically proven Familial Hypercholesterolemia

27 August 2023 (10:15 - 10:45)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment: biomarkers Biomarkers ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Associate Professor Andrea Baragetti

University of Milan, Milan (Italy)

3 More presentations in this session

Presentation thumbnail
The association of lipoprotein(a) with patient characteristics and mortality in a primary prevention cohort: data from our clinic database
Doctor L. Cho (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
Plasma levels of amyloid beta 1-40 are associated with ultrasonographic morphological characteristics related with carotid plaque vulnerability in individuals without cardiovascular disease
Doctor D. Delialis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Association of random glucose to albumin ratio with post-contrast acute kidney injury and clinical outcomes in patients with ST-elevation myocardial infarction
Mr Y. Liu (Guangzhou, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk assessment: biomarkers

The Event

Event poster

ESC Congress 2023

27 August 2023 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Serum proteomic profiling using data-independent acquisition mass spectrometry for familial hypercholesterolemia: a comparative study in a korean population
thumbnail
Congress Presentation
Platelet-Derived-Growth-Factor-Receptor-beta (PDGFB) and atherosclerotic cardiovascular disease presentation in genetically diagnosed familial hypercholesterolemia
thumbnail
Congress Presentation
Analysis of routine molecular genetic diagnostics of familial hypercholesterolemia at tertiary care lipid clinics

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources